Compound information
- Natural Products
- ZC1437358
- Molecular Formula
- C15H21ClN2O4S
- Molecular Weight
- 360.091055832 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-chlorophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H21ClN2O4S/c1-15(2,3)22-14(19)17-8-10-18(11-9-17)23(20,21)13-6-4-12(16)5-7-13/h4-7H,8-11H2,1-3H3
- InChI Key
- XVOBINBTLCYECZ-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1
- Source
- ZINC000001048483
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.007 |
LogS | -4.061 | LogD | 3.672 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.056 | Pgp substrate | 0.013 |
HIA | 0.969 | F20 % | 0.992 |
F30 % | 0.959 | Caco-2 | -4.413 |
MDCK | -4.754 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.926 | PPB | 95.757 |
VD | 2.236 | Fu | 0.911 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.051 | CYP1A2 substrate | 0.497 |
CYP2A6 substrate | 0.664 | CYP2B6 substrate | 0.681 |
CYP2C19 inhibitor | 0.955 | CYP2C19 substrate | 0.844 |
CYP2C8 substrate | 0.685 | CYP2C9 inhibitor | 0.682 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.167 |
CYP2D6 substrate | 0.886 | CYP2E1 substrate | 0.903 |
CYP3A4 inhibitor | 0.243 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.292 | CL | 6.905 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.688 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.109 | Rat Oral Acute Toxicity | 0.268 |
FDAMDD | 0.025 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.924 | Eye Corrosion | 0.017 |
Eye Irritation | 0.017 | Respiratory Toxicity | 0.254 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.704 | IGC50 | 3.376 |
LC50FM | 2.736 | LC50DM | 3.304 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.17 | NR-AR-LBD | 0.291 |
NR-AhR | 0.025 | NR-Aromatase | 0.538 |
NR-ER | 0.242 | NR-ER-LBD | 0.401 |
NR-PPAR-gamma | 0.124 | SR-ARE | 0.784 |
SR-ATAD5 | 0.387 | SR-HSE | 0.086 |
SR-MMP | 0.026 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.